Gene Editing Market size worth over $7.5bn by 2024

1
Gene Editing Market size worth over 7.5bn by
2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Gene Editing Market

• Global gene editing market size will reach USD
  7.5 billion by 2024 growing at 14.9 CAGR from
  2016 to 2024, owing to rising demand for
  synthetic genes and increased production of
  genetically modified crops and organisms.
• CRISPR technology is the fastest growing segment
  with business revenue expected to exceed USD 3
  billion by 2024 owing to wider applications in
  genetic engineering and the speed and specificity
  of edits carried out using it.The technology
  received the U.S. approval for human trial to
  treat certain cancers such as myeloma, melanoma
  and sarcoma.
• Oncology will witness robust 15.9 CAGR over
  forecast period. Cancer will remain one of the
  leading causes of death globally. The business
  segment should exceed USD 874 million by 2024
  owing to growing prevalence of various types of
  cancers.

3
Continued...

• UK genome editing market share accounted for over
  41 of regional revenue size growing at 14.9 to
  reach USD 744 million by 2024. Increasing
  geriatric population along with growing
  prevalence of chronic diseases will fuel business
  growth.
• Key industry players include Agilent
  Technologies, Allele Biotech, Bio Rad,
  AstraZeneca, CRISPR Therapeutics, Dharmacon,
  Cellectis, Editas Medicine, GE Healthcare Lonza,
  Qiagen, Recombinetics, SIGMA-Aldrich and Thermo
  Fisher Scientific. Companies are consolidating
  their industry position by increasing their focus
  on research activities to develop new cost
  effective technologies.

4
U.S. Gene Editing Market Size, by Application,
2013- 2024 (USD Million)

5

Browse Full Market Research Report On Gene
Editing Market _at_ http//bit.ly/2firtKv
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/810 https//www.gminsights.com/request-sample/de
tail/49
6
360 Analysis

• Application Trends
• Gene editing market has its extensive application
  in therapeutic areas of hematology, infectious
  disease, oncology and muscular diseases.
  Hematology was recognized as the highest revenue
  generating segment in 2015, due to extensive use
  in investigating genetic function in experimental
  hematology. Infectious disease segment will also
  follow the robust growth trend with 15.2 CAGR
  during the forecast timeframe contributing to the
  overall revenue of over USD 2.5 billion by 2024.
• Regional Trends
• U.S. gene editing market size was USD 518.5
  million in 2015 due to robust growth trend
  manifested by pharmaceutical and biotechnology
  industries and adoption of advanced technologies
  like CRISPR to treat chronic hereditary
  disorders.
• Competitive Market Share
• Major industry participants for the global gene
  editing market share include Agilent
  Technologies, Allele Biotech, AstraZeneca, Bio
  Rad, Cellectis, CRISPR Therapeutics, Editas
  Medicine, GE Healthcare Dharmacon, Lonza, Qiagen,
  Recombinetics, Sigma-Aldrich and Thermo Fisher
  Scientific.

7
Stay In Touch Website www.gminsights.com Soci
al Media